Literature DB >> 5844157

Spontaneous regression of primary malignant melanomas with regional metastases.

J L Smith, J S Stehlin.   

Abstract

Entities:  

Mesh：

Year:  1965        PMID： 5844157     DOI： 10.1002/1097-0142(196511)18:11<1399::aid-cncr2820181104>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  49 in total

1.  Primary Pulmonary Malignant Melanoma: An Unexpected Tumor.

Authors:  Kyo-Bum Hwang; Ki-Eun Hwang; Jae-Wan Jung; Su-Jin Oh; Mi-Jeong Park; Young-Hoon Jeong; Keum-Ha Choi; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

Review 2.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.

Authors:  R L Barnhill; M A Levy
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

4.  Emerging immune therapy of metastatic melanoma in the older patient: does age really matter?

Authors:  Upendra P Hegde; Bijay Mukherji; Jane M Grant-Kels
Journal:  Melanoma Manag       Date:  2016-02-17

5.  Malignant melanoma involving the small bowel.

Authors:  B G Wilson; J R Anderson
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

6.  [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].

Authors:  B E Paredes
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

Review 7.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Authors:  H J Wanebo; P H Cooper; R W Hagar
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

9.  Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.

Authors:  Jasper G van den Boorn; Debby Konijnenberg; Esther P M Tjin; Daisy I Picavet; Nico J Meeuwenoord; Dmitri V Filippov; J P Wietze van der Veen; Jan D Bos; Cornelis J M Melief; Rosalie M Luiten
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

10.  Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.

Authors:  H H Peter; J R Kalden; P Seeland; V Diehl; G Eckert
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.